RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 133 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $5,445 | -16.4% | 1,500 | 0.0% | 0.00% | – |
| Q2 2021 | $6,510 | +26.9% | 1,500 | 0.0% | 0.00% | – |
| Q1 2021 | $5,130 | -2.3% | 1,500 | 0.0% | 0.00% | – |
| Q4 2020 | $5,250 | +45.8% | 1,500 | 0.0% | 0.00% | – |
| Q3 2020 | $3,600 | +31.1% | 1,500 | 0.0% | 0.00% | – |
| Q2 2020 | $2,745 | +17.3% | 1,500 | 0.0% | 0.00% | – |
| Q1 2020 | $2,340 | -27.1% | 1,500 | 0.0% | 0.00% | – |
| Q4 2019 | $3,210 | +14.4% | 1,500 | 0.0% | 0.00% | – |
| Q3 2019 | $2,805 | -28.4% | 1,500 | 0.0% | 0.00% | – |
| Q2 2019 | $3,915 | +1.6% | 1,500 | 0.0% | 0.00% | – |
| Q1 2019 | $3,855 | +11.7% | 1,500 | 0.0% | 0.00% | – |
| Q4 2018 | $3,450 | -28.3% | 1,500 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $4,815 | +13.4% | 1,500 | 0.0% | 0.00% | – |
| Q2 2018 | $4,245 | -20.1% | 1,500 | 0.0% | 0.00% | -100.0% |
| Q1 2018 | $5,310 | -8.8% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $5,820 | +52.8% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $3,810 | – | 1,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 4,500,000 | $11,925,000 | 4.90% |
| HealthInvest Partners AB | 1,090,000 | $2,889,000 | 4.07% |
| GREAT POINT PARTNERS LLC | 5,000,000 | $13,250,000 | 2.94% |
| CM Management, LLC | 775,000 | $2,054,000 | 1.55% |
| SECTOR GAMMA AS | 1,469,604 | $3,894,000 | 0.92% |
| Sio Capital Management, LLC | 913,621 | $2,421,000 | 0.73% |
| Telemetry Investments, L.L.C. | 190,000 | $504,000 | 0.65% |
| DAFNA Capital Management LLC | 879,000 | $2,329,000 | 0.59% |
| Rock Springs Capital Management LP | 4,860,200 | $12,880,000 | 0.30% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $4,074,000 | 0.27% |